Trial
NCT00700778
Recombinant Human Chorionic Gonadotropin in Preventing Breast Cancer in Premenopausal Women With BRCA1 Mutations
UnknownTERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Fox Chase Cancer Center
Collaborators
National Cancer Institute (NCI)
Condition
BRCA1 Mutation
Intervention
recombinant human chorionic gonadotropin
Why stopped
Unable to recruit volunteers
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-01-25